"The right diagnosis can be life changing- The Rowe Neurology Institute provides caring individualized comprehensive diagnosis and treatment for patients with neurological diseases. We also provide patients with an opportunity to participate in FDA supervised clinical trials in MS, Alzheimer's Disease, Headache, and Sleep Disorders, -disorders for which no cause has been found and no cure is known. We are an independent, free standing Institute, and provide cost effective care for patients with high deductibles. We are out of network, and are independent from all hospital systems and insurance plans, but can work with all of them."

During the past decade, Rowe Neurology Institute conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 7 clinical trials were completed, i.e. on average, 77.8% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 5 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Rowe Neurology Institute" #1 sponsor was "Allergan" with 3 trials, followed by "AbbVie" with 1 trials sponsored, "Balance Therapeutics" with 1 trials sponsored, "Cefaly Technology" with 1 trials sponsored and "Eli Lilly and Company" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

According to Clinical.Site data, the most researched conditions in "Rowe Neurology Institute" are "Migraine, With or Without Aura" (3 trials), "Multiple Sclerosis" (2 trials), "Alzheimer Disease (AD)" (1 trials), "Idiopathic Hypersomnia" (1 trials) and "Insomnia Disorder" (1 trials). Many other conditions were trialed in "Rowe Neurology Institute" in a lesser frequency.

Most popular intervention types in "Rowe Neurology Institute" are "Drug" (8 trials), "Other" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Placebo-matching Ubrogepant" (2 trials), "Ubrogepant" (2 trials), "ABT-555" (1 trials) and "Atogepant" (1 trials). Other intervention names were less common.

The vast majority of trials in "Rowe Neurology Institute" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Rowe Neurology Institute". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Rowe Neurology Institute, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Rowe Neurology Institute, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".

Rowe Neurology Institute has several departments that took part in Clinical trials: "Rowe Neurology Institute RNI - Lenexa" - 2 trials